Stem cells and tissue engineering area at CNC has the following objectives:
1- CELL REPROGRAMMING: the development of strategies for efficient cell reprogramming of somatic cells into hematopoietic stem cells (HSCs) and cardiac cells.
2- STEM CELL MODULATION: the development of strategies to modulate stem cell engraftment and stem cell differentiation.
3- DRUG SCREENING: the development of stem cell–based assays and in silico approaches for drug screening and toxicity assessment.
4- CLINICAL APPLICATIONS: development of new advanced methodologies based in stem cells to heal chronic non-healing wounds in diabetic patients or to regenerate myocardium after infarction.